Inhibition of the Kallikrein-Kinin System in Vasogenic Brain Edema

[1]  A. Unterberg,et al.  Blood Flow, Metabolism, and Function of the Brain During Cerebral Administration of Bradykinin , 1985 .

[2]  A. Unterberg,et al.  Effects of Bradykinin on Permeability and Diameter of Pial Vessels In vivo , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  A. Unterberg,et al.  The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue. , 1984, Journal of neurosurgery.

[4]  A. Unterberg,et al.  The kallikrein-kinin system as mediator in vasogenic brain edema. Part 1: Cerebral exposure to bradykinin and plasma. , 1984, Journal of neurosurgery.

[5]  W. Müller-Esterl,et al.  Monitoring of aprotinin plasma levels by an enzyme-linked immunosorbent assay (ELISA) , 1984 .

[6]  H. Fritz,et al.  Biochemistry and applications of aprotinin, the kallikrein inhibitor from bovine organs. , 1983, Arzneimittel-Forschung.

[7]  H. Segawa,et al.  Role of platelets in vasogenic brain edema. I. Significance of thrombus formation in the damaged vessels. , 1981, Archives of neurology.

[8]  A. Unterberg,et al.  Brain edema factors: current state with particular reference to plasma constituents and glutamate. , 1980, Advances in neurology.

[9]  E. G. Erdös,et al.  Bradykinin, Kallidin and Kallikrein , 1970, Handbook of Experimental Pharmacology / Handbuch der experimentellen Pharmakologie.

[10]  I. Klatzo,et al.  Presidental address. Neuropathological aspects of brain edema. , 1967, Journal of neuropathology and experimental neurology.